Switch theme
Sign up to access all valuation multiples
Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which together with Arm & Hammer constitute around 70% of its annual sales and profits. Most recently, the firm announced the addition of Touchland, and its hand santizer business, to its fold. Even as it works to grow the reach of its products, Church & Dwight still derives around 80% of its sales from its home market in the US.
1925
5.8K+
LTM Revenue $6.1B
LTM EBITDA $1.4B
$24.9B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Church & Dwight has a last 12-month revenue (LTM) of $6.1B and a last 12-month EBITDA of $1.4B.
In the most recent fiscal year, Church & Dwight achieved revenue of $6.1B and an EBITDA of $1.1B.
Church & Dwight expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Church & Dwight valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $6.1B | XXX | $6.1B | XXX | XXX | XXX |
| Gross Profit | $2.7B | XXX | $2.8B | XXX | XXX | XXX |
| Gross Margin | 45% | XXX | 46% | XXX | XXX | XXX |
| EBITDA | $1.4B | XXX | $1.1B | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 18% | XXX | XXX | XXX |
| EBIT | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EBIT Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $858M | XXX | $585M | XXX | XXX | XXX |
| Net Margin | 14% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $1.2B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of July 18, 2025, Church & Dwight's stock price is $97.
Church & Dwight has current market cap of $23.8B, and EV of $24.9B.
See Church & Dwight trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $24.9B | $23.8B | XXX | XXX | XXX | XXX | $3.46 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of July 18, 2025, Church & Dwight has market cap of $23.8B and EV of $24.9B.
Church & Dwight's trades at 4.1x EV/Revenue multiple, and 22.9x EV/EBITDA.
Equity research analysts estimate Church & Dwight's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Church & Dwight has a P/E ratio of 27.7x.
See valuation multiples for Church & Dwight and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $23.8B | XXX | $23.8B | XXX | XXX | XXX |
| EV (current) | $24.9B | XXX | $24.9B | XXX | XXX | XXX |
| EV/Revenue | 4.1x | XXX | 4.1x | XXX | XXX | XXX |
| EV/EBITDA | 17.7x | XXX | 22.9x | XXX | XXX | XXX |
| EV/EBIT | 21.5x | XXX | 21.4x | XXX | XXX | XXX |
| EV/Gross Profit | 9.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 27.7x | XXX | 40.6x | XXX | XXX | XXX |
| EV/FCF | 26.1x | XXX | 25.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialChurch & Dwight's last 12 month revenue growth is 2%
Church & Dwight's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.3M for the same period.
Church & Dwight's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Church & Dwight's rule of X is 28% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Church & Dwight and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| EBITDA Margin | 23% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | 4% | XXX | XXX | XXX |
| Rule of 40 | 24% | XXX | 20% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 28% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $1.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Church & Dwight acquired XXX companies to date.
Last acquisition by Church & Dwight was XXXXXXXX, XXXXX XXXXX XXXXXX . Church & Dwight acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Church & Dwight founded? | Church & Dwight was founded in 1925. |
| Where is Church & Dwight headquartered? | Church & Dwight is headquartered in United States of America. |
| How many employees does Church & Dwight have? | As of today, Church & Dwight has 5.8K+ employees. |
| Who is the CEO of Church & Dwight? | Church & Dwight's CEO is Mr. Richard A. Dierker. |
| Is Church & Dwight publicy listed? | Yes, Church & Dwight is a public company listed on NYS. |
| What is the stock symbol of Church & Dwight? | Church & Dwight trades under CHD ticker. |
| When did Church & Dwight go public? | Church & Dwight went public in 1976. |
| Who are competitors of Church & Dwight? | Similar companies to Church & Dwight include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Church & Dwight? | Church & Dwight's current market cap is $23.8B |
| What is the current revenue of Church & Dwight? | Church & Dwight's last 12 months revenue is $6.1B. |
| What is the current revenue growth of Church & Dwight? | Church & Dwight revenue growth (NTM/LTM) is 2%. |
| What is the current EV/Revenue multiple of Church & Dwight? | Current revenue multiple of Church & Dwight is 4.1x. |
| Is Church & Dwight profitable? | Yes, Church & Dwight is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Church & Dwight? | Church & Dwight's last 12 months EBITDA is $1.4B. |
| What is Church & Dwight's EBITDA margin? | Church & Dwight's last 12 months EBITDA margin is 23%. |
| What is the current EV/EBITDA multiple of Church & Dwight? | Current EBITDA multiple of Church & Dwight is 17.7x. |
| What is the current FCF of Church & Dwight? | Church & Dwight's last 12 months FCF is $956M. |
| What is Church & Dwight's FCF margin? | Church & Dwight's last 12 months FCF margin is 16%. |
| What is the current EV/FCF multiple of Church & Dwight? | Current FCF multiple of Church & Dwight is 26.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
